Manufacturing and royalty revenues from Ampyra/Fampyra (dalfampridine, Acorda Pharmaceuticals Inc. and Biogen Idec Inc.) were $65 million, compared to $24.6 million for the previous fiscal year, and royalty revenue from Bydureon (exenatide, Amylin Pharmaceuticals Inc.) was $16.4 million compared to $1.5 million for the prior fiscal year

The global, randomized Phase IIb TRAVERSE study is testing Pexa-Vec in more than 120 HCC patients who failed prior therapy with Nexavar (sorafenib, Onyx Pharmaceuticals Inc. and Bayer AG

Merrimack Pharmaceuticals Inc., of Cambridge, Mass., enrolled its last patient in a Phase II trial of MM-121 in combination with exemestane in postmenopausal women with locally advanced or metastatic estrogen receptor-positive or HER2-negative breast cancer...OncoGenex Pharmaceuticals Inc., of Bothell, Wash., began a Phase II (Cedar) trial of heat-shock protein 27 (Hsp27) inhibitor OGX-427 for advanced squamous cell lung cancer

AMAG Pharmaceuticals Inc., of Lexington, Mass., said Takeda Pharma AG, a unit of Takeda Pharmaceutical Co

Cyclacel Pharmaceuticals Inc., of Berkeley Heights, N.J., closed an underwritten public offering of 6,833,334 shares of common stock at $3 per share for gross proceeds of $20.5 million...Ironwood Pharmaceuticals Inc., of Cambridge, Mass., priced a public offering of 10.5 million shares of Class A common stock at $13 per share for gross proceeds of $136.5 million...NPS Pharmaceuticals Inc., of Bedminster, N.J., priced a public offering of 6 million shares of stock at $14.53 per share for gross proceeds

It also has Relistor (methylnaltrexone bromide), a drug it picked up in a licensing deal with Tarrytown, N.Y.-based Progenics Pharmaceuticals Inc

In seeking the exemption, AAO focuses on the cost savings compounded Avastin affords compared with the two approved AMD drugs, Roche's Lucentis (ranibizumab) and Regeneron Pharmaceuticals Inc.'s Eylea (aflibercept

Acelrx Pharmaceuticals Inc., of Redwood City, Calif., reported top-line data that showed its sublingual Sufentanil NanoTab PCA (patient-controlled analgesia) System met the primary and secondary efficacy endpoints in a placebo-controlled, Phase III study...AMAG Pharmaceuticals Inc., of Lexington, Mass., reported a new subgroup analysis for a Phase III trial of ferumoxytol in iron deficiency anemia...Regeneron Pharmaceuticals Inc., of Tarrytown, N.Y., and Sanofi SA, of Paris, published results in The

Acadia Pharmaceuticals Inc., of San Diego, completed its public offering of 9.2 million shares, including 1.2 million shares sold to cover overallotments, priced at $12.50 per share, for gross proceeds of $115 million...Ironwood Pharmaceuticals Inc., of Cambridge, Mass., said it commenced a public offering of 10.5 million shares of its Class A common stock...NPS Pharmaceuticals Inc., of Bedminster, N.J., is commencing a public offering of 6 million shares of common stock

Baliopharm GmbH, a subsidiary of Baliopharm AG, of Basel, Switzerland, joined the NEU2 Consortium with a project addressing the recombinant manufacturing of an Fc-free bispecific CD20-CD95 antibody construct (Novotarg) with selectivity for activated B cells and efficacy studies in disease models relevant to multiple sclerosis therapy. The two-year project was funded by the German Federal Ministry of Education and Research. Bayer AG, of Leverkusen, Germany, signed an agreement to acquire the